ReviewVascular2012
Cell-based interventions for therapeutic angiogenesis: review of potential cell sources.
Review in Vascular, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 22 citations in OpenAlex.
- Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study.Clinical transplantation and research · 2026Article
- De novo copy number variations in candidate genomic regions in patients of severe autism spectrum disorder in Vietnam.PloS one · 2024Article
- CD34-Structure, Functions and Relationship with Cancer Stem Cells.Medicina (Kaunas, Lithuania) · 2023Review
- CD34Heart and vessels · 2018Article
- Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy.RSC advances · 2018Article
- An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability.Stem cell research & therapy · 2018Article
- A Murine Model of Hind Limb Ischemia to Study Angiogenesis and Arteriogenesis.Methods in molecular biology (Clifton, N.J.) · 2018Review
- Biological therapies in otology.HNO · 2017Review
- Article
- Biohybrid cochlear implants in human neurosensory restoration.Stem cell research & therapy · 2016Article
- Hypoxia-inducible factor as an angiogenic master switch.Frontiers in pediatrics · 2015Review
- A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier.Stem cells international · 2015Article
- EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation.Cell death & disease · 2014Article
- Concise review: evidence for CD34 as a common marker for diverse progenitors.Stem cells (Dayton, Ohio) · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
Abstract
Alternative therapies are currently being developed to treat patients with chronic limb ischemia who are unable to be revascularized in order to avoid amputation. Cell-based therapy using mononuclear cells is gaining attention as many clinical trials are currently underway. We review cell differentiation along with the different potential cell sources for use in therapeutic angiogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.